These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5590243)

  • 1. Studies on hypercoagulable state. II. The application of 131I-labelled fibrinogen for the estimation of intravascular coagulation in human subjects.
    Izak G; Galewski K; Eyal Z
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):544-51. PubMed ID: 5590243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incorporation of I-125 labelled fibrinogen. Study in normal subjects].
    Langer B; Camargo EE; Mário J; dos Reis M; Carvalho N; Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(2):99-104. PubMed ID: 1265379
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of oral contraceptives on factor VIII levels.
    Crowell EB; Clatanoff DV; Kiekhofer W
    J Lab Clin Med; 1971 Apr; 77(4):551-7. PubMed ID: 5554340
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrotic syndrome. A hypercoagulable state.
    Kendall AG; Lohmann RC; Dossetor JB
    Arch Intern Med; 1971 Jun; 127(6):1021-7. PubMed ID: 5578557
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of hypercoagulable states with protamine sulphate tests.
    Lipinski B
    Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of I-125-fibrinogen for determination of intravascular coagulation in vivo in various organs in the dog.
    Busch C; Lundqvist H; Saldeen T
    Acta Pathol Microbiol Scand A; 1970; 78(4):492. PubMed ID: 5476629
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolism and localization of I 131-fibrinogen in chronic intravascular coagulation].
    Straub PW; Kessler S
    Schweiz Med Wochenschr; 1970 Nov; 100(46):2001-3. PubMed ID: 5507850
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E
    Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of the prethrombotic state in clinical practice].
    Makatsariia AD; Mishchenko AL
    Sov Med; 1982; (6):56-60. PubMed ID: 6750807
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution and turnover of fibrinogen labelled with I-125 in atherosclerotic subjects].
    Cajozzo A; Indovina I; Carreca I
    Haematologica; 1971; 56(11):479-87. PubMed ID: 5004756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in coagulation in patients with sepsis].
    Alarcón G; Fardella P; Conte G; Vargas V; Parada X; Cuneo M
    Rev Med Chil; 1993 May; 121(5):537-41. PubMed ID: 8272635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation changes caused by diagnostic and therapeutic dosage of I-131. II. Therapeutic dose (5 mC)].
    Nenci GG; Casamassima F; Notaristefano A
    Riv Patol Clin Sper; 1969; 10(2):107-12. PubMed ID: 5398166
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and laboratory evaluation of the hypercoagulable states.
    Macik BG; Ortel TL
    Clin Chest Med; 1995 Jun; 16(2):375-87. PubMed ID: 7656547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland.
    Forman WB; Ratnoff OD; Boyer MH
    J Lab Clin Med; 1968 Sep; 72(3):455-72. PubMed ID: 5674077
    [No Abstract]   [Full Text] [Related]  

  • 17. [Congenital dysfibrinogenemia. Apropos of 13 cases].
    Corrihons G; Soria J; Soria C; Conard J; Horellou MH; Samama M
    Sem Hop; 1983 Oct; 59(36):2517-23. PubMed ID: 6316508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does D-dimer help when blood coagulates?].
    Lassila R
    Duodecim; 1999; 115(24):2707-9. PubMed ID: 11979609
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of fibrinogen in cirrhosis of the liver.
    Tytgat GN; Collen D; Verstraete M
    South Med J; 1971 Oct; 64(10):1690-701. PubMed ID: 5125556
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation changes in clinical shock. II. Effect of septic shock on clotting times and fibrinogen in humans.
    Attar S; Mansberger AR; Irani B; Kirby W; Masaitis C; Cowley RA
    Ann Surg; 1966 Jul; 164(1):41-50. PubMed ID: 5947293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.